Walleye Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Walleye Capital’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,258	Closed	-$1.9M	–	3735
2022 Q2	$1.9M	Buy	25,258 +2,702	+12%	+$120K	0.05%	379
2022 Q1	$606K	Buy	+22,556	New	+$758K	0.02%	919

Walleye Capital's TPTX Position: Q3 2022 in Review

Walleye Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 25,258 shares — an estimated $1.9M sold.

Walleye Capital first reported a position in TPTX in Q1 2022 and held it in 2 quarters. The position peaked at $1.9M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Walleye Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Walleye Capital sold 25,258 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.9M.
Walleye Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Walleye Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.9M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.